Misoone (Misoprostol)

Misoprostol, the active ingredient in Misoone, is a prostaglandin E1 analog presented as an oral tablet for oral use. It protects the gastric lining and induces uterine smooth‑muscle contraction, making it useful in ulcer prevention and certain obstetric procedures.

GNH USA supplies Misoone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards, provides regulatory documentation for global distribution, and supports clinical and procurement teams across multiple continents.

Misoprostol acts on prostaglandin pathways to protect the gastrointestinal mucosa and to stimulate uterine activity.

- NSA‑induced gastric ulcer: prevents ulcer formation by enhancing mucus and bicarbonate secretion while reducing acid output. - Medical termination of pregnancy: induces uterine contractions to facilitate expulsion of pregnancy tissue. - Induction of labor: promotes cervical ripening and uterine contractions to initiate delivery. - Management of postpartum hemorrhage: contracts uterine muscle to reduce bleeding after delivery.

Misoprostol may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Abdominal pain: cramping or discomfort in the stomach area. - Diarrhea: loose, watery stools occurring shortly after dosing. - Nausea or vomiting: feeling sick or expelling stomach contents. - Fever or chills: transient elevation of body temperature with shaking.

Serious or Rare Side Effects: - Uterine rupture: tearing of the uterine wall, especially with high doses. - Severe hemorrhage: excessive bleeding during obstetric use. - Anaphylaxis: life‑threatening allergic reaction with rash, swelling, and airway compromise.

Use of misoprostol requires careful assessment of patient conditions and adherence to safety guidelines.

- Pregnancy: contraindicated (Category X) due to risk of fetal harm. - Renal impairment: use with caution; monitor kidney function. - Cardiovascular disease: assess risk of uterine hyperstimulation. - Concomitant NSAIDs: avoid high‑dose combinations that may increase adverse effects. - Store at ambient temperature below 25°C: keep in original packaging, protect from moisture.

Misoprostol can interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Prostaglandin synthesis inhibitors (e.g., indomethacin): may reduce misoprostol’s gastric protective effect. - Oxytocin: concurrent use may cause excessive uterine contractions. - High‑dose NSAIDs: increase risk of uterine hyperstimulation.

Moderate Interactions (Monitor Closely): - Antacids: may decrease absorption, reducing efficacy. - Rifampin: induces metabolism, potentially lowering drug levels. - Anticoagulants: may enhance bleeding risk during obstetric use.